S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
TSE:HSM

Helius Medical Technologies Stock Forecast, Price & News

C$15.88
-0.36 (-2.22 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
C$14.64
Now: C$15.88
C$16.13
50-Day Range
C$16.24
MA: C$18.57
C$21.30
52-Week Range
C$12.25
Now: C$15.88
C$40.00
Volume3,707 shs
Average Volume7,723 shs
Market CapitalizationC$36.70 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

Headlines

10 Stocks Moving In Monday's After Hours Session
October 19, 2020 |  finance.yahoo.com
Helius Medical Technologies, Inc. (HSM.TO)
October 6, 2020 |  finance.yahoo.com
LD Micro 360 Companies --Set to Present this Week.
September 2, 2020 |  finance.yahoo.com
Helius Medical Technologies CEO resigns
August 25, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone215-944-6100
Employees19
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$622,000.00
Cash FlowC$1.77 per share
Book ValueC$2.47 per share

Profitability

Miscellaneous

Market CapC$36.70 million
Next Earnings Date3/10/2021 (Confirmed)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
C$15.88
-0.36 (-2.22 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HSM News and Ratings via Email

Sign-up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Helius Medical Technologies (TSE:HSM) Frequently Asked Questions

What stocks does MarketBeat like better than Helius Medical Technologies?

Wall Street analysts have given Helius Medical Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Helius Medical Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Helius Medical Technologies' next earnings date?

Helius Medical Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Helius Medical Technologies
.

How has Helius Medical Technologies' stock price been impacted by COVID-19 (Coronavirus)?

Helius Medical Technologies' stock was trading at C$0.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HSM stock has increased by 2,168.6% and is now trading at C$15.88.
View which stocks have been most impacted by COVID-19
.

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the following people:
  • Mr. Dane Carl Andreeff, Interim Pres & CEO and Director (Age 55, Pay $2.5k)
  • Ms. Joyce N. LaViscount, CFO, COO & Sec. (Age 59, Pay $388.3k)
  • Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 63, Pay $201.65k)
  • Dr. Brian W. Bapty Ph.D., VP of Strategy and Bus. Devel. (Age 52)

Who are some of Helius Medical Technologies' key competitors?

What other stocks do shareholders of Helius Medical Technologies own?

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM."

How do I buy shares of Helius Medical Technologies?

Shares of HSM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Helius Medical Technologies' stock price today?

One share of HSM stock can currently be purchased for approximately C$15.88.

How much money does Helius Medical Technologies make?

Helius Medical Technologies has a market capitalization of C$36.70 million and generates C$622,000.00 in revenue each year.

How many employees does Helius Medical Technologies have?

Helius Medical Technologies employs 19 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is heliusmedical.com.

How can I contact Helius Medical Technologies?

The company can be reached via phone at 215-944-6100.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.